Watchlist Price Alert

Neurogene Inc. (NGNE)

NASDAQ: NGNE · Real-Time Price · USD

13.00

-2.11 (-13.96%)

At close: May 06, 2025, 3:59 PM

12.72

-2.15%

Pre-market: May 07, 2025, 04:00 AM EDT

Neurogene Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-75.14M	-36.32M	-55.19M	-50.52M	-33.28M	-69.44M	-31.59M	-50.18M	-37M
Depreciation & Amortization	3.25M	3.3M	3.2M	947K	1.82M	340K	n/a	n/a	n/a
Stock-Based Compensation	8.32M	1.42M	1.25M	896K	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-5.88M	-4.69M	912K	-1.39M	966K	-2.24M	-5.43M	917K	4.71M
Other Non-Cash Items	-1.06M	-15.69M	608K	679K	9.56M	56.05M	5.44M	4.55M	2.07M
Deferred Income Tax	n/a	-105K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-5.96M	-4.02M	-2.69M	1.59M	966K	-1.95M	-5.43M	917K	4.71M
Operating Cash Flow	-70.6M	-51.42M	-52.82M	-46.4M	-24.57M	-15.39M	-31.58M	-44.72M	-30.23M
Capital Expenditures	-808K	-321K	-2.23M	-18.37M	-2.22M	-879K	-49K	-494K	-713K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	191K	n/a	n/a	n/a
Purchase of Investments	-198.45M	n/a	n/a	n/a	n/a	n/a	n/a	-6M	-106.44M
Sales Maturities Of Investments	n/a	5M	n/a	n/a	n/a	n/a	56M	70.5M	59.1M
Other Investing Acitivies	74M	20.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-125.26M	25.64M	-2.23M	-18.37M	-2.22M	-688K	55.95M	64.01M	-48.06M
Debt Repayment	-52K	-29K	-1K	n/a	-49K	-9K	-32K	-15K	-4K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-5.47M	168K	73K	287K	n/a	n/a	n/a	n/a	0.00
Financial Cash Flow	184.07M	92.48M	66.53M	51.06M	77.14M	82.24M	570K	423K	71.11M
Net Cash Flow	-11.79M	66.7M	11.48M	-13.71M	49.46M	66.17M	24.9M	19.73M	-7.17M
Free Cash Flow	-71.41M	-51.74M	-55.05M	-64.77M	-26.79M	-16.27M	-31.63M	-45.21M	-30.94M